全文获取类型
收费全文 | 1350228篇 |
免费 | 94442篇 |
国内免费 | 2297篇 |
专业分类
耳鼻咽喉 | 19081篇 |
儿科学 | 40433篇 |
妇产科学 | 36455篇 |
基础医学 | 210681篇 |
口腔科学 | 36891篇 |
临床医学 | 120464篇 |
内科学 | 250686篇 |
皮肤病学 | 28096篇 |
神经病学 | 100582篇 |
特种医学 | 53121篇 |
外国民族医学 | 221篇 |
外科学 | 207775篇 |
综合类 | 31339篇 |
现状与发展 | 4篇 |
一般理论 | 363篇 |
预防医学 | 102831篇 |
眼科学 | 31584篇 |
药学 | 102986篇 |
1篇 | |
中国医学 | 2661篇 |
肿瘤学 | 70712篇 |
出版年
2018年 | 12640篇 |
2015年 | 12588篇 |
2014年 | 17565篇 |
2013年 | 26464篇 |
2012年 | 37066篇 |
2011年 | 39905篇 |
2010年 | 23077篇 |
2009年 | 21167篇 |
2008年 | 37132篇 |
2007年 | 40762篇 |
2006年 | 40087篇 |
2005年 | 39199篇 |
2004年 | 38399篇 |
2003年 | 36952篇 |
2002年 | 35624篇 |
2001年 | 55763篇 |
2000年 | 56954篇 |
1999年 | 47806篇 |
1998年 | 14004篇 |
1997年 | 12494篇 |
1996年 | 12444篇 |
1995年 | 11712篇 |
1994年 | 11043篇 |
1992年 | 39603篇 |
1991年 | 40562篇 |
1990年 | 40178篇 |
1989年 | 39037篇 |
1988年 | 36259篇 |
1987年 | 35937篇 |
1986年 | 33864篇 |
1985年 | 32767篇 |
1984年 | 24992篇 |
1983年 | 21313篇 |
1982年 | 12700篇 |
1981年 | 11699篇 |
1980年 | 11028篇 |
1979年 | 24957篇 |
1978年 | 17981篇 |
1977年 | 14889篇 |
1976年 | 14443篇 |
1975年 | 16324篇 |
1974年 | 19569篇 |
1973年 | 18810篇 |
1972年 | 17742篇 |
1971年 | 16603篇 |
1970年 | 15764篇 |
1969年 | 15033篇 |
1968年 | 13767篇 |
1967年 | 12566篇 |
1966年 | 11369篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
F W Fraunfelder F T Fraunfelder D R Illingworth 《The British journal of ophthalmology》1995,79(1):54-56
In a retrospective survey of patients taking medication for hyperlipidaemia, those taking niacin (nicotinic acid) were more likely (p < 0.05) to report sicca syndromes, blurred vision, eyelid oedema, and macular oedema compared with those who never took niacin. Additionally, 7% of those taking niacin discontinued the drug owing to adverse ocular side effects, while none of the other lipid lowering agents were found to cause these side effects (p = 0.016). Data from spontaneous reporting systems support a possible association of decreased vision, cystoid macular oedema, sicca-like symptoms, discoloration of the eyelids with or without periorbital or eyelid oedema, proptosis, loss of eyebrow or eyelashes, and superficial punctate keratitis with the use of niacin in high doses. Decreased vision may be marked, and if the drug is not discontinued, may progress to cystoid macular oedema. All ocular side effects listed above are reversible if the association with niacin is recognised and the drug is discontinued; both the incidence and severity of the ocular side effects seem to be dose dependent. 相似文献
53.
54.
C Schmitt J Brachmann W Saggau T Beyer B Waldecker K Scharowski T Hilbel M Montero B Offner W Sch?ls 《Zeitschrift für Kardiologie》1991,80(11):665-672
In 41 patients with recurrent sustained ventricular tachycardia and/or ventricular fibrillation an integrated pacemaker-defibrillator-system (PCD, Medtronic, model 7216 A or 7217 B) was implanted. In 21 out of 24 (88%) patients a new transvenous implantation technique in combination with a subcutaneous patch electrode was used. The implanted devices comprise antibradycardiac pacemaker functions, two different forms of antitachycardiac pacemaker functions (ramp and burst pacing), and internal cardioversion or defibrillation capabilities. During a mean follow-up of 8 months 147 episodes of ventricular tachycardia were detected, 131 of them were terminated successfully by antitachycardiac pacing; in 13 episodes internal cardioversion was applied to revert ventricular tachycardia. Twenty-seven episodes of ventricular fibrillation or rapid ventricular tachycardia (greater than 200/min) were detected and successfully terminated by internal defibrillation. In six patients with intermittent rapid atrial fibrillation, change of antiarrhythmic therapy was required to avoid activation of the device. The new integrated pacemaker-defibrillator systems improve therapy in patients with life-threatening tachyarrhythmias by reducing the number of internal cardioversions/defibrillations; the non-thoracotomy approach reduces the post operative risk. 相似文献
55.
The effect of localized hyperthermia on blood flow and cis-diamminedichloroplatinum(II) (CDDP) pharmacokinetics in 7,12-dimethylbenz[a]anthracene-induced mammary adenocarcinomas was studied. Blood flow was determined in rat tumors and normal tissue immediately and 1, 2, and 3 h after local hyperthermia treatment (43 degrees C, 1 h) as well as in unheated tumors of rats. The rate of blood flow in the tumor was increased 1.9 times at the end of treatment relative to control values and returned to the control values by 3 h after hyperthermia. Similarly, the rate of blood flow in the peripheral skin around the tumor immediately after hyperthermia was 2.2 times greater than that of unheated skin and returned to near normal values by 3 h after heating. Tumor-bearing rats received CDDP 1 h before, at the beginning of, at the end of, and 1 h after hyperthermia administration. The CDDP plasma concentration versus time profiles for rats did not vary statistically between treatment groups. Two h after CDDP administration, the mean tumor CDDP concentration of the rats which received drug at the beginning of hyperthermia was statistically greater (P less than 0.05) than tumor CDDP concentrations in rats which received drug at the end of heat treatment. The latter group was given CDDP when tumor blood flow was the greatest; however, mean tumor drug concentration was lowest of all the groups. The mean drug concentration in tumor tissues of rats which received drug 1 h after hyperthermia was comparable to rats which received drug at the beginning of hyperthermia. This suggests that drug delivery or uptake in tumors may be altered when local hyperthermia is administered concurrently or sequentially. 相似文献
56.
P J Hayden C J Welsh Y Yang W H Schaefer A J Ward J L Stevens 《Chemical research in toxicology》1992,5(2):232-237
Nephrotoxic cysteine conjugates derived from a variety of halogenated alkenes are enzymatically activated via the beta-lyase pathway to yield reactive sulfur-containing metabolites which bind covalently to cellular macromolecules. Mitochondria contain beta-lyase enzymes and are primary targets for binding and toxicity. Previously, mitochondrial protein and/or DNA have been considered as molecular targets for cysteine conjugate metabolite binding. We now report that metabolites of nephrotoxic cysteine conjugates form covalent adducts with rat kidney mitochondrial phospholipids. Rat kidney mitochondria were incubated with the 35S-labeled conjugates S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC), S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine (CTFC), S-(1,2-dichlorovinyl)-L-cysteine, and S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine. Quantitation of metabolite binding to whole mitochondria and to mitochondrial protein and lipid fractions revealed that as much as 42% of the 35S-label associated with the mitochondria was found in the lipid fraction. Total lipids were also extracted from 35S-treated mitochondria and separated by thin-layer chromatography. 35S-Containing metabolites were found in the lipid fractions from mitochondria treated with each of the conjugates. Lipids from both [35S]CTFC- and [35S]-TFEC-treated mitochondria contained major 35S-labeled lipid adducts which had similar mobility by thin-layer chromatography. Fatty acid analysis, 19F and 31P NMR spectroscopy, and mass spectrometric analyses confirmed that the major TFEC and CTFC adducts are thioamides of phosphatidylethanolamine. 相似文献
57.
C.I.V. FRANKLIN 《Journal of Medical Imaging and Radiation Oncology》1992,36(1):44-47
This paper examines the effect of patient age, tumour grade and extent of surgery on the outcome of treatment of 278 patients with high grade malignant gliomas referred to the Queensland Radium Institute between 1980 and 1987. The aim was to determine whether the extent of surgical resection alters survival rates. The extent of surgery had no effect on survival except for those patients with grade 3 tumours in whom a total excision was possible. Those in whom only a biopsy was done did not have a worse prognosis. Grading was found to be of importance, as patients with grade 3 tumours had a better survival than those with grade 4 tumours. In grade 4 tumours, those under 30 years of age had a better survival than those over 30 years, whereas with grade 3 tumours there was a gradation of age effect (under 40 years best, then 40–49 years, and those 50 years and over doing worst). 相似文献
58.
59.
60.